首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations
【24h】

MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations

机译:MA16.04具有同时TP53和RB1突变的EGFR突变体肺癌的临床和分子特征

获取原文
获取原文并翻译 | 示例
       

著录项

  • 来源
  • 作者单位

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

    Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York;

    Pathology Memorial Sloan Kettering Cancer Center New York;

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

    Department of Pathology - Molecular Diagnostics Memorial Sloan Kettering Cancer Center New York;

    Department of Pathology Memorial Sloan Kettering Cancer Center New York;

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

    Medical Oncology Memorial Sloan Kettering Cancer Center New York;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

  • 入库时间 2022-08-19 19:53:06

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号